Cargando…

Glycolytic Genes Predict Immune Status and Prognosis Non-Small-Cell Lung Cancer Patients with Radiotherapy and Chemotherapy

BACKGROUND: Non-small-cell lung cancer (NSCLC) is a major health problem that endangers human health. The prognosis of radiotherapy or chemotherapy is still unsatisfactory. This study is aimed at investigating the predictive value of glycolysis-related genes (GRGs) on the prognosis of NSCLC patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Tianye, Shao, Jingjing, Liu, Jia, Wang, Yidan, Chen, Jia, He, Song, Wang, Gaoren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125743/ https://www.ncbi.nlm.nih.gov/pubmed/37101691 http://dx.doi.org/10.1155/2023/4019091

Ejemplares similares

EHD2 inhibits the invasive ability of lung adenocarcinoma and improves the prognosis of patients
por: Wei, Sheng, et al.
Publicado: (2022)

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma
por: Guo, Jing, et al.
Publicado: (2022)

Monitoring early dynamic changes of plasma cell-free DNA and pretreatment pre-albumin to predict chemotherapy effectiveness and survival outcomes in advanced non-small cell lung cancer
por: Chen, Jia, et al.
Publicado: (2022)

The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study
por: Wei, Sheng, et al.
Publicado: (2022)

Based on the Development and Verification of a Risk Stratification Nomogram: Predicting the Risk of Lung Cancer-Specific Mortality in Stage IIIA-N2 Unresectable Large Cell Lung Neuroendocrine Cancer Compared With Lung Squamous Cell Cancer and Lung Adenocarcinoma
por: Yang, Ying, et al.
Publicado: (2022)

Glycolytic and fatty acid oxidation genes affect the treatment and prognosis of liver cancer
por: Zou, Jia-Yue, et al.
Publicado: (2022)

Based on disulfidptosis-related glycolytic genes to construct a signature for predicting prognosis and immune infiltration analysis of hepatocellular carcinoma
por: Wang, Zhijian, et al.
Publicado: (2023)

Advances in the study of aerobic glycolytic effects in resistance to radiotherapy in malignant tumors
por: Liu, Yuyi, et al.
Publicado: (2023)

Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer
por: Lee, Shin Yup, et al.
Publicado: (2016)

Role of cuproptosis-related gene in lung adenocarcinoma
por: Liu, Yuan, et al.
Publicado: (2022)

Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer
por: Talebian Yazdi, Mehrdad, et al.
Publicado: (2016)

The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
por: Su, ShengFa, et al.
Publicado: (2014)

Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy
por: Ouyang, Wei-Wei, et al.
Publicado: (2014)

A Two-eRNA-Based Signature Can Impact the Immune Status and Predict the Prognosis and Drug Sensitivity of Lung Adenocarcinoma
por: Wang, Li, et al.
Publicado: (2022)

HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways
por: Bao, Chuncha, et al.
Publicado: (2022)

Construction of Glycolytic Regulator Gene Signature to Predict the Prognosis and Tumor Immune Cell Infiltration Levels for Prostate Cancer
por: Zhang, Ling, et al.
Publicado: (2022)

Radiotherapy for oligometastatic tumor improved the prognosis of patients with non‐small cell lung cancer (NSCLC)
por: Gong, Hong‐yun, et al.
Publicado: (2019)

Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration
por: Zhang, Yuying, et al.
Publicado: (2022)

Genomic and Glycolytic Entropy Are Reliable Radiogenomic Heterogeneity Biomarkers for Non-Small Cell Lung Cancer
por: Chen, Yu-Hung, et al.
Publicado: (2023)

Advance in integrating platinum-based chemotherapy with radiotherapy for locally advanced nasopharyngeal carcinoma
por: Zhu, Fubin, et al.
Publicado: (2023)

Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
por: Xu, Huan, et al.
Publicado: (2022)

The Importance of Marital Status in the Morbidity and Prognosis of Lung Metastasis in Newly Diagnosed Ovarian Cancer
por: Qian, Lihui, et al.
Publicado: (2023)

Three months treatment with chemotherapy and radiotherapy for small cell lung cancer.
por: Thatcher, N., et al.
Publicado: (1985)

The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma
por: Gao, Jingyan, et al.
Publicado: (2022)

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
por: He, Jia, et al.
Publicado: (2021)

Enhanced expression of FGF19 predicts poor prognosis in patients with non-small cell lung cancer
por: Chen, Jia, et al.
Publicado: (2021)

Heterogeneity in clinical prognosis, immune infiltration and molecular characteristics of three glycolytic subtypes in lower-grade gliomas
por: Wu, Shenglian, et al.
Publicado: (2023)

Prognosis-related molecular subtyping in head and neck squamous cell carcinoma patients based on glycolytic/cholesterogenic gene data
por: Zhou, Zekun, et al.
Publicado: (2023)

Regulations of Glycolytic Activities on Macrophages Functions in Tumor and Infectious Inflammation
por: Yu, Qing, et al.
Publicado: (2020)

Effect of radiotherapy upon enzymes of the glycolytic and related pathways in human uterine cancer.
por: Marshall, M. J., et al.
Publicado: (1979)

The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients
por: He, Jia, et al.
Publicado: (2022)

The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas
por: Jang, Se Min, et al.
Publicado: (2012)

Rev-erbα inhibits proliferation by reducing glycolytic flux and pentose phosphate pathway in human gastric cancer cells
por: Tao, Linlin, et al.
Publicado: (2019)

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
por: Chen, Peixin, et al.
Publicado: (2021)

Glycolytic lactate production supports status epilepticus in experimental animals
por: Skwarzynska, Daria, et al.
Publicado: (2023)

Exploring Non-Metabolic Functions of Glycolytic Enzymes in Immunity
por: Seki, Scott M., et al.
Publicado: (2017)

The Roles of EXO1 and RPA1 Polymorphisms in Prognosis of Lung Cancer Patients Treated with Platinum-Based Chemotherapy
por: He, Jia, et al.
Publicado: (2022)

Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy
por: Zhu, Kaibo, et al.
Publicado: (2021)

Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion
por: Lin, Jichun, et al.
Publicado: (2023)

Typical tumor immune microenvironment status determine prognosis in lung adenocarcinoma
por: Ren, Caixia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_536aj96jar5735r64a7fk8djij